Despite efforts by governments in Latin America, illicit drugs continue to provide one of the largest incomes for criminal organizations, enabling them to penetrate and corrupt political and social institutions.
Jamaica's current volatile security environment and its economic malaise are reasons enough to seriously consider joining their Latin American counterparts to debate a raft of new policy options, not only in rhetoric, but also through public policy. Our prison conditions and local magistrate courts are bursting at their seams from inmate overcrowding and case overloads for marijuana possession that amount to miniscule consumption levels.
Poor young men, slumdwellers and single mothers are hurt the most by anti-drug policies in Latin America, according to representatives of governments, social organisations and multilateral bodies meeting at the Fifth Latin American Conference on Drug Policies held in San José, Costa Rica. Activists, experts and decision-makers from throughout the region demanded reforms of these policies, to ease the pressure on vulnerable groups and shift the focus of law enforcement measures to those who benefit the most from the drug trade.
Ending the consumption and the trafficking of illegal drugs is “impossible”, according to Felipe Calderón, Mexico’s outgoing president. In an interview with The Economist Mr Calderón, whose battle with organised crime has come to define his six years in office, said that countries whose citizens consume drugs should find "market mechanisms" to prevent their money from getting into the hands of criminals in Latin America.
This is at the heart of the awakening in Latin America, a feeling that drugs prohibition has allowed rich and powerful cartels to rise to such prominence that they threaten the institutions of the state – the police, the judicial system, the army, the media, and the body politic. In Latin America it is not about rehab and criminality, it is about an existential threat to the state.
The House of Commons will today debate whether to rethink the war on drugs. While it is only a backbench business debate, and is therefore not binding, it still represents a step towards reviewing the UK’s drug laws. There is a simple reason why the UK’s drug policy is so expensive and ineffective: the law is so old. Policy is still dictated by the 1971 Misuse of Drugs Act, signed into law shortly after the 1971 UN Convention on Drugs. In 43 years since, the approach has failed catastrophically.